Biotricity Inc.
BTCY- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630113
No open-market purchases or sales by Biotricity Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $5.99K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Biotricity Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Biotricity Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rosa David A | Director | 152,174 | Mar 15, 2023 | 0 |
| Al-Siddiq Waqaas | President, CEO and Chairman | – | Mar 14, 2023 | 0 |
| Ayanoglou John | Chief Financial Officer | – | Mar 13, 2023 | 0 |
| Betts Norman M. | Director | 375,598 | Dec 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 (view filing) | Oct 7-11 | 6 daysLate | Rosa David ADirector | SSale | −30.0K | $3.11 | −$93.5K | −19.4%125.0K after | 3 lots |
| Sep 29, 2021 (view filing) | Sep 15-16 | 14 daysLate | Rosa David ADirector | SSale | −41.2K | $3.41 | −$140.4K | −21.0%155.0K after | 2 lots |